Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Antibiotics (Basel) ; 11(12)2022 Nov 24.
Article in English | MEDLINE | ID: mdl-36551351

ABSTRACT

Blood cultures should be collected within an hour in the setting of sepsis/septic shock. The contamination rate should be below 3%. Worldwide reports have described an increase in blood contamination rates during the COVID-19 pandemic. We performed a retrospective analysis of the blood cultures collected during a 10-month period (March−December 2020) at NIID "Prof. Dr. Matei Balș". The results were compared with data from the pre-pandemic period (March−December 2016) and with the existing data in the literature. During the pandemic, there was a significant decrease in the number of blood cultures collected (1274 blood cultures in 2020 vs. 5399 in 2016). The contamination rate was higher in 2020 (11.7%) compared to 2016 (8.2%), p < 0.001. The rate of infectious episodes in which the etiological agent was identified was constant: 11% in 2020 versus 11.9% in 2016, p = 0.479, but there were fewer invasive bacterial/fungal infections: 0.95/1000 patient days in 2020 vs. 2.39/1000 patient days in 2016, p < 0.001. We observed a change in the species distribution. The Gram-negative isolate's proportion increased from 50.6% to 63.1% and the gram-positive isolate's proportion decreased from 31.8% to 19%. Collection of a low number of blood cultures and a high contamination rate was identified in our clinic. In order to improve the usefulness of blood cultures as a diagnostic method, at least two sets should be collected in aseptic conditions.

2.
Rom J Intern Med ; 49(4): 289-94, 2011.
Article in English | MEDLINE | ID: mdl-22568274

ABSTRACT

There has been an increase in recent years of antimicrobial resistance of Gram negative bacilli (GNB). Carbapenems, the mainstay for the treatment of multidrug resistant GNB infections, are no longer always effective leaving treatment options limited. We present the case of patient with recurrent, complicated urinary tract infections. The current episode was caused by carbapenem-resistant K. pneumoniae and P. aeruginosa and carbapenem-susceptible, but MDR E. cloacae. Resistance to carbapenems of K. pneumoniae was conferred by the production of the class B metallo-beta-lactamase, VIM1. Infection control measures were implemented and following a 2-week course of treatment with colistin, the infection resolved and the patient was discharged. We discuss the changes in the epidemiology, the mechanisms involved and the means of detecting carbapenem resistance in GNB. We would also like to stress the role of infection control measures in limiting patient-to-patient spread of MDR organisms which, are of paramount importance in cases when few treatment options are left available.


Subject(s)
Carbapenems/administration & dosage , Drug Resistance, Multiple, Bacterial , Enterobacter cloacae , Enterobacteriaceae Infections , Klebsiella Infections , Klebsiella pneumoniae , Urinary Tract Infections , Aged , Anastomosis, Surgical/adverse effects , Anti-Bacterial Agents/administration & dosage , Colistin/administration & dosage , Enterobacter cloacae/isolation & purification , Enterobacter cloacae/pathogenicity , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae Infections/etiology , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/transmission , Humans , Infection Control , Klebsiella Infections/drug therapy , Klebsiella Infections/etiology , Klebsiella Infections/microbiology , Klebsiella Infections/transmission , Klebsiella pneumoniae/isolation & purification , Klebsiella pneumoniae/pathogenicity , Male , Nephrolithiasis/complications , Pseudomonas Infections/drug therapy , Pseudomonas Infections/etiology , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/isolation & purification , Risk Factors , Treatment Outcome , Urinary Bladder/surgery , Urinary Bladder Neoplasms/complications , Urinary Bladder Neoplasms/surgery , Urinary Tract Infections/drug therapy , Urinary Tract Infections/etiology , Urinary Tract Infections/microbiology , Urinary Tract Infections/transmission , beta-Lactam Resistance
SELECTION OF CITATIONS
SEARCH DETAIL
...